Cardiac Science Reports Record Fourth Quarter and Full Year 20...(ur AED distribution globally and to incr...),Health

Date:2/28/2008

ur AED distribution globally and to increase investment in product development to help achieve our growth potential. In addition, with a strong balance sheet, growing cash reserves and no debt, we expect to accelerate efforts to seek acquisition opportunities, particularly those which can leverage our existing service and distribution capabilities," he continued.

The Company expects revenue growth for 2008 to be in a range around 10%, driven by continued growth in global AED revenues, meaningful revenue from the hospital defibrillator product and modest improvement in the cardiac monitoring line.

For 2008, gross margin is expected to be in a range between 47% and 49%, depending on several factors, including product pricing, the mix of sales through different distribution channels, and the timing of the impact of planned productivity increases and cost reductions.

The Company expects to increase its investment in research and development in 2008, increasing related expenses to between 7.5% and 8% of revenue. Other operating expenses are expected to grow in 2008 also, but at rates generally less than the rate of revenue growth, which would result in increased operating income in 2008.

The Company expects net income, inclusive of an estimated income tax rate of 37%, to be in a range between $8 and $9 million, or between $0.34 and $0.39 per share, representing earnings growth of 13% to 27%. Adjusted EBITDA is expected to be in a range between 11% and 12% of revenue.

Michael Matysik, senior vice president and chief financial officer, stated, "A number of factors may affect our actual results relative to the ranges we've provided. These include GE's level of success in selling our new hospital defibrillator, the tempo and results of our continued effort to revitalize our cardiac monitoring line and our ability to continue to capture share of the international AED market as it rapidly evolves." Mr. Matysik added, "Our revenue guidance als
'/>"/>

SOURCE Cardiac Science Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk